GB-Policy&Regulation (Premium-1): Lead Exposure Is Still a Problem for Kids, and the Pandemic Has Made It Worse

Lead exposure continues to threaten the health and development of children across the country, despite longstanding efforts to eliminate this toxic hazard from homes, schools, and communities. The COVID-19 pandemic has exacerbated the problem, as lockdowns and school closures have increased children’s time in potentially hazardous environments and disrupted routine lead screenings and prevention programs. Many families, especially those in underserved areas, now face greater challenges in accessing resources and support. As a result, the risk of lead poisoning and its lifelong consequences has grown, underscoring the urgent need for renewed public health attention and intervention.

Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.

Children COVID Vaccination
India Has Multiple COVID-19 Vaccines For Children. How Are They Faring? • Source: Shutterstock

The good news – if it’s possible to describe a slow, insidious, and permanent poisoning as “good news” – is that the blood lead levels of children in the United States have dropped steadily over the past half-century.

Quick Facts

  1. Lead is a toxic metal that can harm children’s brain development, even at low levels of exposure.
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Policy & Regulation

UK Invests £28m In NHS AI, But Industry Says Procurement And Training Will Determine Success - C11

 
• By 

The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.

UK Invests £28m In NHS AI, But Industry Says Procurement And Training Will Determine Success - C10

 
• By 

The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.

Test Regulatory Recap: Ireland To See Earlier Off-Patent Medicines Launches As A State Deal Passes

 

Also, Latest News From Europe, Canada, Saudi Arabia, Finland, China, And The US

ADHD

This is regarding ADHD.

More from Regulation

Kashiv Finishes Patient Recruitment In Late Stage Xolair Biosimilar Trial

 
• By 

Following on from its recently announced US licensing deal with Amneal over its Xolair biosimilar, Kashiv has finished patient recruitment for a trial for the omalizumab candidate, paving the way for submissions.

GB-Policy&Regulation (Premium-1): Lead Exposure Is Still a Problem for Kids, and the Pandemic Has Made It Worse

 
• By 

Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.